# Program 1 Phase Q0 - Scope and Non-Validation Boundaries

Phase Q performs validation planning only.

Phase Q does not perform implementation, execution, evidence review, validation approval, safety certification, real-data approval, or production authorization.

| Term | Definition | Phase Q Status |
| --- | --- | --- |
| Validation planning | Documentation of intended validation objectives, test categories, evidence requirements, owners, acceptance criteria, negative tests, regression policy, and readiness gates. | performed as documentation only |
| Test implementation | Actual test code, automation, fixtures, CI changes, or test harnesses. | not performed |
| Test execution | Running tests and collecting results for a specific release or control. | not performed |
| Test evidence review | Formal review of test outputs and evidence completeness. | not performed |
| Validation approval | Formal acceptance that the tested control/system meets predefined criteria. | not granted |
| Safety certification | A separate formal determination that is not granted by Phase Q. | not granted |
| Production authorization | A separate future production-use decision that is not granted by Phase Q. | not granted |

## Explicit Boundaries

- no production approval
- no real patient data approval
- no PHI/PII ingestion authorization
- no validation claim
- no safety certification
- no test implementation that changes behavior
- no authentication, authorization, RBAC or audit logging implementation
- no runtime control implementation
- no clinical automation
- no patient messaging
- no appointment mutation
- no Task engine
- no Outcome Evidence
- no approval/clearance/override workflow

## Non-Validation Statement

Phase Q is a future-state validation and safety planning artifact. It is not evidence that the described tests exist, have run, have passed, or have been reviewed.
